Rebecca Bond, DO
Neurology · Muskegon, MINPI 1912319757
Payments from drug & device makers
Across 258 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$726
- Pfizer$409
- Otsuka America Pharmaceutical, Inc.$309
- Lundbeck LLC$296
- Neurocrine Biosciences, Inc.$231
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,171100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 108 | $1,279 |
| Teva Pharmaceuticals USA, Inc. | 15 | $726 |
| Pfizer | 28 | $409 |
| Otsuka America Pharmaceutical, Inc. | 18 | $309 |
| Lundbeck LLC | 16 | $296 |
| Neurocrine Biosciences, Inc. | 4 | $231 |
| Acadia Pharmaceuticals Inc | 11 | $209 |
| UCB, Inc. | 4 | $170 |
| Novartis | 10 | $151 |
| SK Life Science, Inc. | 7 | $144 |
| Jazz Pharmaceuticals Inc. | 2 | $130 |
| Greenwich Biosciences, Inc. | 1 | $125 |
| Amgen | 1 | $125 |
| Lilly USA, LLC | 2 | $123 |
| Eisai Inc. | 1 | $118 |
| Argenx US, Inc. | 4 | $101 |
| Neurelis, Inc. | 3 | $84 |
| Genentech USA, Inc. | 3 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $61 |
| Boehringer Ingelheim | 4 | $59 |
| AstraZeneca | 2 | $50 |
| Biogen | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Avanir Pharmaceuticals, Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| TG Therapeutics, Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $18 |
| Electromed, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,171 in reported general payments places this provider in the 65th percentile of 652 neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dimethyl Fumarate | 13 | $52,308 |
| Emgality PenGalcanezumab-Gnlm | 18 | $13,009 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 158 | $6,702 |
| Carbidopa | 16 | $3,104 |
| Propranolol Hcl ErPropranolol Hcl | 55 | $2,992 |
| Memantine Hcl | 67 | $2,267 |
| Levetiracetam | 51 | $2,153 |
| Oxcarbazepine | 16 | $1,661 |
| Divalproex Sodium ErDivalproex Sodium | 20 | $1,391 |
| Donepezil Hcl | 67 | $1,357 |
| Pyridostigmine Bromide | 30 | $1,302 |
| Rivastigmine | 11 | $1,297 |
| Atorvastatin Calcium | 62 | $1,254 |
| Lacosamide | 12 | $1,194 |
| Gabapentin | 89 | $1,158 |
Paid to pharmacies, not to this prescriber.
Other neurology in Muskegon
- Patrick PavwoskiMuskegon$242K
- Aaron EllenbogenFarmington Hills$14.5M
- Martin BelkinFarmington Hills$5.8M
- Evanthia BernitsasDetroit$4.8M
- Yang Mao DraayerFarmington Hills$4.2M
- Mirela CerghetDetroit$3.8M
- Peter le WittWest Bloomfield$3.2M
- Judith HeidebrinkAnn Arbor$2.2M
- Denise LeungAnn Arbor$2M
- Rany AburashedOwosso$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.